Detalhe da pesquisa
1.
2023 FIGO staging system for endometrial cancer: The evolution of the revolution.
Gynecol Oncol
; 184: 245-253, 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38447389
2.
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancer.
Gynecol Oncol
; 185: 128-137, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38412736
3.
Changing cancer mindsets: A randomized controlled feasibility and efficacy trial.
Psychooncology
; 32(9): 1433-1442, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37529924
4.
Changing Mindsets About Side Effects of the COVID-19 Vaccination: A Randomized Controlled Trial.
Ann Behav Med
; 57(11): 901-909, 2023 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279932
5.
Germline Genetic Testing After Cancer Diagnosis.
JAMA
; 330(1): 43-51, 2023 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37276540
6.
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
Lancet Oncol
; 23(8): e374-e384, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35901833
7.
Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer.
Gynecol Oncol
; 166(2): 254-262, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35718565
8.
Greater financial toxicity relates to greater distress and worse quality of life among breast and gynecologic cancer survivors.
Psychooncology
; 31(1): 9-20, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34224603
9.
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study.
Int J Gynecol Cancer
; 32(6): 761-768, 2022 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086926
10.
Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee.
Gynecol Oncol
; 161(2): 502-507, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33612336
11.
Cell-based immunotherapy in gynecologic malignancies.
Curr Opin Obstet Gynecol
; 33(1): 13-18, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33278077
12.
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.
Lancet Oncol
; 20(5): 636-648, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30948273
13.
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
N Engl J Med
; 375(22): 2154-2164, 2016 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27717299
14.
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.
J Natl Compr Canc Netw
; 17(8): 896-909, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31390583
15.
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial.
Lancet Oncol
; 19(8): 1117-1125, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30026000
16.
Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer.
Qual Life Res
; 27(1): 59-74, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29248998
17.
Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study.
Oncologist
; 22(9): 1117-1124, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28596446
18.
Impact of the 2014 Food and Drug Administration Warnings Against Power Morcellation.
J Minim Invasive Gynecol
; 23(4): 548-56, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26827905
19.
Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study.
Int J Gynecol Cancer
; 24(9): 1583-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25254563
20.
Contraceptive strategies for reducing the risk of reproductive cancers.
Int J Gynaecol Obstet
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38725288